↓ Skip to main content

Dove Medical Press

Beta-blockers: friend or foe in asthma?

Overview of attention for article published in International Journal of General Medicine, July 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (83rd percentile)
  • High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

twitter
9 X users
facebook
1 Facebook page
wikipedia
1 Wikipedia page

Citations

dimensions_citation
10 Dimensions

Readers on

mendeley
54 Mendeley
Title
Beta-blockers: friend or foe in asthma?
Published in
International Journal of General Medicine, July 2013
DOI 10.2147/ijgm.s46592
Pubmed ID
Authors

Bente Arboe, Charlotte Suppli Ulrik

Abstract

Recently, β-blockers have been suggested as a potential maintenance treatment option for asthma. The aim of this review is to provide an overview of the current knowledge of the potential benefits and risks of β-blocker therapy for asthma.

X Demographics

X Demographics

The data shown below were collected from the profiles of 9 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 54 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Finland 1 2%
Unknown 53 98%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 10 19%
Student > Ph. D. Student 7 13%
Student > Doctoral Student 7 13%
Researcher 6 11%
Student > Master 4 7%
Other 12 22%
Unknown 8 15%
Readers by discipline Count As %
Medicine and Dentistry 30 56%
Nursing and Health Professions 4 7%
Pharmacology, Toxicology and Pharmaceutical Science 3 6%
Agricultural and Biological Sciences 2 4%
Computer Science 1 2%
Other 3 6%
Unknown 11 20%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 August 2023.
All research outputs
#4,203,375
of 25,584,565 outputs
Outputs from International Journal of General Medicine
#200
of 1,627 outputs
Outputs of similar age
#33,917
of 207,028 outputs
Outputs of similar age from International Journal of General Medicine
#5
of 28 outputs
Altmetric has tracked 25,584,565 research outputs across all sources so far. Compared to these this one has done well and is in the 83rd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,627 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.5. This one has done well, scoring higher than 87% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 207,028 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 83% of its contemporaries.
We're also able to compare this research output to 28 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 85% of its contemporaries.